Gastrointestinal Drugs Market Global Briefing 2018

Gastrointestinal Drugs Market Global Briefing 2018

  • January 2018 •
  • 33 pages •
  • Report ID: 5057817
The gastrointestinal diseases drugs market covers medicines used for the treatment of ulcerative colitis, diverticular disease, perianal infections, anal fissures, hemorrhoids, constipation, and irritable bowel syndrome. The key gastrointestinal diseases drug categories include Anti-peptic agents (antacids, antagonists, Proton Pump Inhibitors, Sucralfate, and Misoprostol), antiemetics, adsorbents, anticholinergics, opiates, intestinal flora modifiers, emollient/surfactants, hyperosmotic, saline, and simulant/irritant.

North America was the largest region in the gastrointestinal drugs market in 2017, accounting for around 30% market share. This was mainly due to the high prevalence of obesity and digestive diseases due to unhealthy lifestyle in the North American countries. According to the National Center for Health Statistics, more than one-third (36.5%) of U.S adults were obese during 2011-2014. Asia Pacific was the second largest region accounting for around 26% market share. Western Europe was the third largest region accounting for around 19% market share.

Tranexamic Acid To Treat Gastrointestinal Bleeding - Drug manufacturing companies are offering tranexamic acid for the treatment of acute gastrointestinal bleeding. Tranexamic acid is a medication used to treat or prevent excessive blood loss from major trauma or surgery and is now finding applications for gastrointestinal diseases.

Tranexamic acid reduces clot breakdown, thus reducing the duration and amount of bleeding. This reduces mortality rate (from 10% to 7.5%) and the probability of blood transfusion by about 30%. Major companies manufacturing tranexamic acid include Abbott Laboratories, Pfizer, GlaxoSmithKline and Bayer AG.

We are very sorry, but an error occurred.
Please contact if the problem remains.

Country=World Industry=OTC ParentIndustry=Pharmaceutical Date=201801 Topic=MarketReport Publisher=TheBusinessResearchCompany Price=1000